The Galvus (Vildagliptin) test assesses the effectiveness of this medication in controlling blood sugar levels in patients with type 2 diabetes. The test aims to measure blood glucose levels, as well as evaluate the drug’s effect on Hemoglobin A1c levels.

Patients with Type 2 Diabetes: Receiving Vildagliptin treatment to monitor the drug’s effectiveness in controlling blood sugar levels. Individuals with persistently high glucose levels: To assess the body’s response to treatment and determine if the dosage is appropriate. Patients with recent treatment modifications: To evaluate the impact of changes in therapy on blood sugar levels. Individuals aiming to improve diabetes control: As part of comprehensive disease management. Individuals with diabetes complications: To monitor the effect of treatment on blood glucose levels and improve overall health.

High Blood Sugar Levels: Such as excessive thirst, frequent urination, and persistent fatigue. Weight Changes: Either unexplained weight loss or weight gain. Difficulty Controlling Blood Sugar Levels: Such as not achieving therapeutic targets despite adherence to treatment. Hyperglycemia Symptoms: Such as nausea, headache, and blurred vision. Hypoglycemia Symptoms: Such as dizziness, excessive sweating, and tremors.

What is the purpose of this test? It is used to assess the effectiveness of Vildagliptin (Galvus) in controlling blood sugar levels in patients with type 2 diabetes. How is the test performed? It involves taking a blood sample, usually done in a medical laboratory. How long does it take to get the results? Results typically take a few days to a week, depending on the laboratory. Does the test require special preparation? In some cases, fasting may be recommended before the test, so it is advisable to consult the doctor regarding any specific instructions. What are the risks associated with the test? The risks are minimal and may include mild pain when the sample is taken. What do the test results mean? High or low results indicate the effectiveness of the drug and its impact on blood sugar levels, which may require treatment adjustment. Can other medications affect the test results? Yes, some medications may affect blood sugar levels, so it is recommended to inform the doctor about all medications and supplements being taken.

Normal fasting level ranges between 70 and 99 mg/dL. After eating, levels below 140 mg/dL are considered normal. Normal level is less than 5.7%. Levels between 5.7% and 6.4% indicate prediabetes. 6.5% or higher is considered a diabetes diagnosis.

Vildagliptin (Galvus) Level Test | Lahalak Platform

A specialized test measuring Vildagliptin levels in the blood to ensure optimal glucose control and safely enhance treatment plans for type 2 diabetes management.

Prices starts from: 264 SAR

Scientific name: Vildagliptin (Galvus) Level Test

The Vildagliptin test is used to evaluate the effectiveness of the medication vildagliptin in managing blood glucose levels in patients with type 2 diabetes. Vildagliptin belongs to the DPP-4 inhibitor class, which works by increasing the levels of hormones responsible for regulating glucose in the body, helping improve glycemic control. This test...

Vildagliptin (Galvus) Level Test - Monitor Galvus Medication Levels

Service type Laboratory test (Blood)

Duration 10-15 minutes

Fasting Fasting is not required

Prices Starting from 264 SAR

Included Services

Galvus (Vildagliptin) Test
The optimal health guidance based on the result.
Personal support services from Lahalak

Medical Service Information

Purpose Test

The Galvus (Vildagliptin) test assesses the effectiveness of this medication in controlling blood sugar levels in patients with type 2 diabetes. The test aims to measure blood glucose levels, as well as evaluate the drug’s effect on Hemoglobin A1c levels.

Recommended groups

Patients with Type 2 Diabetes: Receiving Vildagliptin treatment to monitor the drug’s effectiveness in controlling blood sugar levels.
Individuals with persistently high glucose levels: To assess the body’s response to treatment and determine if the dosage is appropriate.
Patients with recent treatment modifications: To evaluate the impact of changes in therapy on blood sugar levels.
Individuals aiming to improve diabetes control: As part of comprehensive disease management.
Individuals with diabetes complications: To monitor the effect of treatment on blood glucose levels and improve overall health.

Symptoms indicative

High Blood Sugar Levels: Such as excessive thirst, frequent urination, and persistent fatigue.
Weight Changes: Either unexplained weight loss or weight gain.
Difficulty Controlling Blood Sugar Levels: Such as not achieving therapeutic targets despite adherence to treatment.
Hyperglycemia Symptoms: Such as nausea, headache, and blurred vision.
Hypoglycemia Symptoms: Such as dizziness, excessive sweating, and tremors.

FAQs

What is the purpose of this test? It is used to assess the effectiveness of Vildagliptin (Galvus) in controlling blood sugar levels in patients with type 2 diabetes.
How is the test performed? It involves taking a blood sample, usually done in a medical laboratory.
How long does it take to get the results? Results typically take a few days to a week, depending on the laboratory.
Does the test require special preparation? In some cases, fasting may be recommended before the test, so it is advisable to consult the doctor regarding any specific instructions.
What are the risks associated with the test? The risks are minimal and may include mild pain when the sample is taken.
What do the test results mean? High or low results indicate the effectiveness of the drug and its impact on blood sugar levels, which may require treatment adjustment.